The global market for Research ELISA (Enzyme-Linked Immunosorbent Assay) was valued at US$559.1 Million in 2024 and is projected to reach US$692.3 Million by 2030, growing at a CAGR of 3.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
ELISA's robustness and versatility stem from its ability to deliver highly specific and sensitive results, making it indispensable in both clinical and research settings. In clinical diagnostics, ELISA is crucial for disease detection, including viral and bacterial infections, autoimmune diseases, and allergies. For instance, it is commonly used in the detection of HIV, hepatitis, and SARS-CoV-2. In the food industry, ELISA helps ensure food safety by detecting allergens, toxins, and contaminants. Moreover, environmental agencies employ ELISA to monitor pollutants and pathogens in water and soil. The assay's adaptability is further enhanced by the development of various formats, such as direct, indirect, sandwich, and competitive ELISA, each tailored for specific analytical needs.
Enzyme-Linked Immunosorbent Assay (ELISA) is a widely utilized analytical biochemistry assay, designed for detecting and quantifying substances such as peptides, proteins, antibodies, and hormones. This assay leverages the specificity of antibodies to detect the presence of specific biomolecules in complex samples. ELISA operates on the principle of antigen-antibody interactions, where an enzyme-linked antigen or antibody produces a measurable signal, typically a color change, in the presence of its target molecule. This technique has found extensive applications in diagnostics, quality control, and research across various fields including clinical diagnostics, food safety, and environmental monitoring.
Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market - Key Trends and Drivers Summarized
The growth in the ELISA market is driven by several factors including advancements in technology, increasing prevalence of chronic and infectious diseases, and the rising demand for cost-effective and reliable diagnostic methods. Technological innovations, such as the development of automated and high-throughput ELISA systems, have significantly improved the efficiency and accuracy of the assays. The surge in chronic diseases like cancer and diabetes, alongside emerging infectious diseases, has amplified the need for precise diagnostic tools, thus boosting the demand for ELISA. Additionally, the growing trend towards personalized medicine and the expanding application of ELISA in drug development and monitoring therapeutic responses have further fueled market growth. The increasing awareness and regulatory emphasis on food and environmental safety also contribute to the expanding ELISA market, as these assays are vital for ensuring compliance with safety standards.ELISA's robustness and versatility stem from its ability to deliver highly specific and sensitive results, making it indispensable in both clinical and research settings. In clinical diagnostics, ELISA is crucial for disease detection, including viral and bacterial infections, autoimmune diseases, and allergies. For instance, it is commonly used in the detection of HIV, hepatitis, and SARS-CoV-2. In the food industry, ELISA helps ensure food safety by detecting allergens, toxins, and contaminants. Moreover, environmental agencies employ ELISA to monitor pollutants and pathogens in water and soil. The assay's adaptability is further enhanced by the development of various formats, such as direct, indirect, sandwich, and competitive ELISA, each tailored for specific analytical needs.
Enzyme-Linked Immunosorbent Assay (ELISA) is a widely utilized analytical biochemistry assay, designed for detecting and quantifying substances such as peptides, proteins, antibodies, and hormones. This assay leverages the specificity of antibodies to detect the presence of specific biomolecules in complex samples. ELISA operates on the principle of antigen-antibody interactions, where an enzyme-linked antigen or antibody produces a measurable signal, typically a color change, in the presence of its target molecule. This technique has found extensive applications in diagnostics, quality control, and research across various fields including clinical diagnostics, food safety, and environmental monitoring.
Report Scope
The report analyzes the Research ELISA (Enzyme-Linked Immunosorbent Assay) market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below.Segments
Segment (ELISA Kits, ELISA Development Sets & Antibody Pairs); End-Use (Hospitals & Diagnostic Centers, Research Laboratories).Geographic Regions/Countries
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.Key Insights:
- Market Growth: Understand the significant growth trajectory of the ELISA Kits segment, which is expected to reach US$478.6 Million by 2030 with a CAGR of a 3.4%. The ELISA Development Sets & Antibody Pairs segment is also set to grow at 4.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $150.3 Million in 2024, and China, forecasted to grow at an impressive 6.1% CAGR to reach $140.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Research ELISA (Enzyme-Linked Immunosorbent Assay) Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as American Laboratory Products Company (ALPCO) (US), BD Biosciences (US), BioLegend, Inc. (US), Bio-Rad Laboratories, Inc. (US), Enzo Life Sciences, Inc. (US) and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 27 companies featured in this Research ELISA (Enzyme-Linked Immunosorbent Assay) market report include:
- American Laboratory Products Company (ALPCO) (US)
- BD Biosciences (US)
- BioLegend, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Enzo Life Sciences, Inc. (US)
- Merck KGaA
- Mercodia AB (Sweden)
- R&D Systems, Inc. (US)
- Thermo Fischer Scientific Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- American Laboratory Products Company (ALPCO) (US)
- BD Biosciences (US)
- BioLegend, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Enzo Life Sciences, Inc. (US)
- Merck KGaA
- Mercodia AB (Sweden)
- R&D Systems, Inc. (US)
- Thermo Fischer Scientific Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 266 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 559.1 Million |
| Forecasted Market Value ( USD | $ 692.3 Million |
| Compound Annual Growth Rate | 3.6% |
| Regions Covered | Global |
